These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Development of bioadhesive amino-pegylated poly(anhydride) nanoparticles designed for oral DNA delivery. Yoncheva K; Centelles MN; Irache JM J Microencapsul; 2008 Mar; 25(2):82-9. PubMed ID: 18246486 [TBL] [Abstract][Full Text] [Related]
9. Multifunctional Poly(methyl vinyl ether-co-maleic anhydride)-graft-hydroxypropyl-β-cyclodextrin Amphiphilic Copolymer as an Oral High-Performance Delivery Carrier of Tacrolimus. Zhang D; Pan X; Wang S; Zhai Y; Guan J; Fu Q; Hao X; Qi W; Wang Y; Lian H; Liu X; Wang Y; Sun Y; He Z; Sun J Mol Pharm; 2015 Jul; 12(7):2337-51. PubMed ID: 26024817 [TBL] [Abstract][Full Text] [Related]
10. Quantification of the bioadhesive properties of protein-coated PVM/MA nanoparticles. Arbós P; Arangoa MA; Campanero MA; Irache JM Int J Pharm; 2002 Aug; 242(1-2):129-36. PubMed ID: 12176235 [TBL] [Abstract][Full Text] [Related]
11. Influence of dextran on the bioadhesive properties of poly(anhydride) nanoparticles. Porfire AS; Zabaleta V; Gamazo C; Leucuta SE; Irache JM Int J Pharm; 2010 May; 390(1):37-44. PubMed ID: 19712734 [TBL] [Abstract][Full Text] [Related]
12. Bioadhesive poly(methyl vinyl ether-co-maleic anhydride)-TPGS copolymer modified PLGA/lipid hybrid nanoparticles for improving intestinal absorption of cabazitaxel. Ren T; Zheng X; Bai R; Yang Y; Jian L Int J Pharm; 2022 Jan; 611():121301. PubMed ID: 34793933 [TBL] [Abstract][Full Text] [Related]
13. An HPLC with evaporative light scattering detection method for the quantification of PEGs and Gantrez in PEGylated nanoparticles. Zabaleta V; Campanero MA; Irache JM J Pharm Biomed Anal; 2007 Sep; 44(5):1072-8. PubMed ID: 17587532 [TBL] [Abstract][Full Text] [Related]
14. PEGylated human serum albumin (HSA) nanoparticles: preparation, characterization and quantification of the PEGylation extent. Fahrländer E; Schelhaas S; Jacobs AH; Langer K Nanotechnology; 2015 Apr; 26(14):145103. PubMed ID: 25789544 [TBL] [Abstract][Full Text] [Related]
16. Influence of the surface characteristics of PVM/MA nanoparticles on their bioadhesive properties. Arbós P; Campanero MA; Arangoa MA; Renedo MJ; Irache JM J Control Release; 2003 Apr; 89(1):19-30. PubMed ID: 12695060 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the cytotoxicity, genotoxicity and mucus permeation capacity of several surface modified poly(anhydride) nanoparticles designed for oral drug delivery. Iglesias T; López de Cerain A; Irache JM; Martín-Arbella N; Wilcox M; Pearson J; Azqueta A Int J Pharm; 2017 Jan; 517(1-2):67-79. PubMed ID: 27908629 [TBL] [Abstract][Full Text] [Related]
18. Bioadhesive properties and biodistribution of cyclodextrin-poly(anhydride) nanoparticles. Agüeros M; Areses P; Campanero MA; Salman H; Quincoces G; Peñuelas I; Irache JM Eur J Pharm Sci; 2009 Jun; 37(3-4):231-40. PubMed ID: 19491010 [TBL] [Abstract][Full Text] [Related]
19. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Hadinoto K; Sundaresan A; Cheow WS Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180 [TBL] [Abstract][Full Text] [Related]
20. pH-labile PEGylation of siRNA-loaded lipid nanoparticle improves active targeting and gene silencing activity in hepatocytes. Hashiba K; Sato Y; Harashima H J Control Release; 2017 Sep; 262():239-246. PubMed ID: 28774839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]